Are These Multibillion-Dollar Vaccine Stocks Still a Buy?

Pharmaceutical companies Moderna (MRNA -6.74%) and Merck (MRK -0.39%) saw their shares rise 19.6% and 1.7%, respectively, on Tuesday after they announced impressive early results from their mRNA cancer vaccine to prevent melanoma, the deadliest form of skin cancer. Both companies' shares continued…#mrna #keytruda #talimogene #stellar #acceleronpharma #sotatercept #btk #melanomaresearchfoundation #mrk #pah
Source: Reuters: Health - Category: Consumer Health News Source Type: news